{"title_page": "Substance use disorder", "text_new": "{{short description|Continual use of drugs (including alcohol) despite detrimental consequences}}\n{{Use dmy dates|date=December 2018}}\n{{Infobox medical condition (new)\n| name            = Substance use disorder\n| synonyms        = Drug use disorder\n| image           = Syringe-1884784_1920.jpg\n| caption         = \n| pronounce       = \n| speciality      = [[Psychiatry]], [[clinical psychology]]\n| symptoms        = \n| complications   = \n| onset           = \n| duration        = \n| types           = \n| causes          = \n| risks           = \n| diagnosis       = \n| differential    = \n| prevention      = \n| treatment       = \n| medication      = \n| prognosis       = \n| frequency       = \n| deaths          = \n}}\n'''Substance use disorder''' ('''SUD'''), also known as a '''drug use disorder''', is the persistent use of drugs (including alcohol) despite substantial adverse consequences.<ref>{{Cite book|title=Diagnostic and statistical manual of mental disorders.|date=2013|publisher=American Psychiatric Association|isbn=978-0-89042-554-1|edition=5|page=483|location=Arlington, VA|oclc=830807378}}</ref><ref>{{cite web | url=http://www.nami.org/Content/ContentGroups/Policy/Issues_Spotlights/DSM5/Substance_Use_Disorder_Paper_4_13_2010.pdf | title=NAMI Comments on the APA's Dr aft Revision of the DSM-V Substance Use Disorders | publisher=National Alliance on Mental Illness | access-date=2 November 2013 | url-status=dead | archive-url=https://web.archive.org/web/20150122085833/http://www.nami.org/content/contentgroups/policy/issues_spotlights/dsm5/substance_use_disorder_paper_4_13_2010.pdf | archive-date=22 January 2015 }}</ref> Substance use disorders are characterized by an array of mental, physical, and behavioral symptoms that may cause problems related to loss of control, strain to one's interpersonal life, hazardous use, tolerance, and withdrawal.<ref name = \"DSM5\">{{cite book |title=Diagnostic and statistical manual of mental disorders. |publisher=American Psychiatric Association |isbn=978-0-89042-554-1 |edition=5 |date=2013 |url-access=registration |url=https://archive.org/details/diagnosticstatis0005unse }}</ref> Drug classes that are involved in SUD include: [[Alcoholism|alcohol]]; [[Caffeine dependence|caffeine]]; [[Cannabis (drug)|cannabis]]; hallucinogens (such as [[arylcyclohexylamine]]s); other hallucinogens (such as [[Lysergic acid diethylamide|LSD]]); [[inhalant]]s; [[Opioid use disorder|opioids]]; [[sedative]]s, [[hypnotic]]s, or [[anxiolytic]]s; [[stimulant]]s; [[Tobacco smoking|tobacco]]; and other or unknown substances.<ref>{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK519702/|title=Substance Use Disorders| author =Substance Abuse and Mental Health Services Administration |date=June 2016|publisher=Substance Abuse and Mental Health Services Administration (US)}}</ref>\n\nIn the [[DSM-5]], [[substance abuse]] and [[substance dependence]] have been merged into the category of substance use disorders.<ref>{{Cite journal|last=Guha|first=Martin | name-list-format = vanc |date=2014-03-11|title=Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (5th edition)|journal=Reference Reviews|volume=28 |issue=3 |doi=10.1108/RR-10-2013-0256|issn=0950-4125}}</ref><ref name=\"Hasin_2013\">{{cite journal | vauthors = Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF | display-authors = 6 | title = DSM-5 criteria for substance use disorders: recommendations and rationale | journal = The American Journal of Psychiatry | volume = 170 | issue = 8 | pages = 834\u201351 | date = August 2013 | pmid = 23903334 | pmc = 3767415 | doi = 10.1176/appi.ajp.2013.12060782 }}</ref> The severity of substance use disorders can vary widely; in the diagnosis of a SUD, the severity of an individual's SUD is qualified as ''mild'', ''moderate'', or ''severe'' on the basis of how many of the [[#Diagnosis|11 diagnostic criteria]] are met. In the DSM-5, the term ''drug addiction'' is synonymous with ''severe substance use disorder''.<ref name=\"Brain disease\" /><ref name=\"Surgeon General severe SUD\" />\n\n<!-- Epidemiology -->\nIn 2017 globally 271 million people (5.5% of adults) were estimated to have used one or more illicit drugs.<ref name=WDR2019>{{cite web |title=World Drug Report 2019: 35 million people worldwide suffer from drug use disorders while only 1 in 7 people receive treatment |url=https://www.unodc.org/unodc/en/frontpage/2019/June/world-drug-report-2019_-35-million-people-worldwide-suffer-from-drug-use-disorders-while-only-1-in-7-people-receive-treatment.html?ref=fs1#_ftnref1 |website=www.unodc.org |access-date=25 November 2019}}</ref> Of these 35 million had a substance use disorder.<ref name=WDR2019/>\n\nIn 2017 substance use disorders resulted in 585,000 deaths,<ref name=WDR2019/> up from 165,000 deaths in 1990.<ref name=\"GBD2015\" /><ref name=\"GDB2013\">{{cite journal | vauthors = Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, etal | collaboration = GBD 2013 Mortality and Causes of Death Collaborators | title = Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | journal = Lancet | volume = 385 | issue = 9963 | pages = 117\u201371 | date = January 2015 | pmid = 25530442 | pmc = 4340604 | doi = 10.1016/S0140-6736(14)61682-2 }}</ref> Of these, the highest numbers are from [[alcohol use disorders]] at 137,500, [[opioid use disorder]]s at 122,100 deaths, [[amphetamine use disorder]]s at 12,200 deaths, and [[cocaine use disorder]]s at 11,100.<ref name=\"GBD2015\">{{cite journal | title = Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 | journal = Lancet | volume = 388 | issue = 10053 | pages = 1459\u20131544 | date = October 2016 | pmid = 27733281 | pmc = 5388903 | doi = 10.1016/s0140-6736(16)31012-1 | last1 = Wang | first1 = Haidong | last2 = Naghavi | first2 = Mohsen | last3 = Allen | first3 = Christine | last4 = Barber | first4 = Ryan M. | last5 = Bhutta | first5 = Zulfiqar A. | last6 = Carter | first6 = Austin | last7 = Casey | first7 = Daniel C. | last8 = Charlson | first8 = Fiona J. | last9 = Chen | first9 = Alan Zian | last10 = Coates | first10 = Matthew M. | last11 = Coggeshall | first11 = Megan | last12 = Dandona | first12 = Lalit | last13 = Dicker | first13 = Daniel J. | last14 = Erskine | first14 = Holly E. | last15 = Ferrari | first15 = Alize J. | last16 = Fitzmaurice | first16 = Christina | last17 = Foreman | first17 = Kyle | last18 = Forouzanfar | first18 = Mohammad H. | last19 = Fraser | first19 = Maya S. | last20 = Fullman | first20 = Nancy | last21 = Gething | first21 = Peter W. | last22 = Goldberg | first22 = Ellen M. | last23 = Graetz | first23 = Nicholas | last24 = Haagsma | first24 = Juanita A. | last25 = Hay | first25 = Simon I. | last26 = Huynh | first26 = Chantal | last27 = Johnson | first27 = Catherine O. | last28 = Kassebaum | first28 = Nicholas J. | last29 = Kinfu | first29 = Yohannes | last30 = Kulikoff | first30 = Xie Rachel | displayauthors = 29 }}</ref> The number of deaths directly caused by drug use has increased over 60 percent from 2000 to 2015.<ref>{{Cite web|url=https://www.unodc.org/wdr2018/prelaunch/|title=Prelaunch|website=www.unodc.org|access-date=14 December 2018}}</ref>\n\n==Signs and symptoms==\nAddiction is a [[brain disorder]] characterized by compulsive drug use (i.e., the use of drugs due to irresistible urges or \"cravings\") despite negative consequences.<ref name=\":8\">{{Cite web|url=https://www.drugabuse.gov/publications/media-guide/science-drug-use-addiction-basics|title=The Science of Drug Use and Addiction: The Basics|last=Abuse|first=National Institute on Drug|website=www.drugabuse.gov|access-date=2019-11-19}}</ref> The medical community makes a distinction between [[physical dependence]] and [[psychological dependence]] upon drugs.<ref>{{Cite web|url=https://americanaddictioncenters.org/the-addiction-cycle/psychological-dependence|title=What Is Psychological Dependence?|last=Staff|first=Editorial|website=American Addiction Centers|access-date=2019-11-18}}</ref> [[Physical dependence]] refers to the process by which the body adapts to the drug, requiring more of it to achieve a certain effect (tolerance) and eliciting drug-specific symptoms upon cessation (characterized by symptoms of physical [[Drug withdrawal|withdrawal]] symptoms, like [[tremor]]s and sweating).<ref name=\":9\">{{Cite web|url=https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/frequently-asked-questions/there-difference-between-physical-dependence|title=Is there a difference between physical dependence and addiction?|last=Abuse|first=National Institute on Drug|website=www.drugabuse.gov|access-date=2019-11-19}}</ref> Conversely, [[psychological dependence]] occurs when a drug becomes central to a person's thoughts, emotions and activities.<ref name=\":7\">{{Cite web|url=https://www1.health.gov.au/internet/publications/publishing.nsf/Content/drugtreat-pubs-front6-fa-toc~drugtreat-pubs-front6-fa-secb~drugtreat-pubs-front6-fa-secb-8~drugtreat-pubs-front6-fa-secb-8-3|title=Department of Health {{!}} 8.3 Physical and psychological dependence|website=www1.health.gov.au|access-date=2019-11-19}}</ref> They may have strong desire to use the drug, despite being aware of its harmful effects.  A drug can cause physical dependence and not psychological dependence (for example, a person who is physically dependent on prescribed opioid medications may not experience a loss of control, strong cravings, etc.) and some can cause psychological dependence without physical dependence (the withdrawal symptoms associated with [[cocaine]] are all psychological, there is no associated vomiting or diarrhea as there is with opiate withdrawal).<ref>{{Cite web|url=https://www.centeronaddiction.org/the-buzz-blog/understanding-difference-between-physical-dependence-and-addiction|title=Understanding the Difference between Physical Dependence and Addiction {{!}} Center on Addiction|website=www.centeronaddiction.org|access-date=2019-11-19}}</ref>\n\n== Causes ==\nThere are many known risk factors associated with an increased chance of developing a substance use disorder. Children born to parents with SUDs have roughly a two-fold increased risk in developing a SUD compared to children born to parents without any SUDs.<ref name=\":5\">{{Cite book|title=Ferri's Clinical Advisor|last=Ferri|first=Fred|publisher=Elsevier|year=2019|isbn=|location=|pages=}}</ref> Taking highly addictive drugs, and those who develop SUDs in their teens are more likely to have continued symptoms into adulthood.<ref name=\":5\" />  Other common risk factors are being male, being under 25, having other mental health problems, and lack of familial support and supervision.<ref name=\":5\" /> [[Personality theories of addiction|Psychological risk factors]] include high [[impulsivity]], [[sensation seeking]], [[neuroticism]] and [[openness to experience]] in combination with low [[conscientiousness]].<ref>{{cite journal | vauthors = Belcher AM, Volkow ND, Moeller FG, Ferr\u00e9 S | title = Personality traits and vulnerability or resilience to substance use disorders | journal = Trends in Cognitive Sciences | volume = 18 | issue = 4 | pages = 211\u20137 | date = April 2014 | pmid = 24612993 | pmc = 3972619 | doi = 10.1016/j.tics.2014.01.010 }}</ref><ref>{{cite book |last1= Fehrman|first1= Elaine|last2=  Egan|first2=Vincent |last3= Gorban|first3= Alexander N. |last4= Levesley|first4= Jeremy |last5= Mirkes|first5= Evgeny M.  |last6= Muhammad|first6=Awaz K. | name-list-format = vanc |date= 2019|title= Personality Traits and Drug Consumption. A Story Told by Data|url= |doi= 10.1007/978-3-030-10442-9|location= |publisher= Springer, Cham|page= |isbn=978-3-030-10441-2 |author-link= |arxiv= 2001.06520  }}</ref>\n\n== Diagnosis ==\n{{addiction glossary|reverse citation order=yes}}\nIndividuals whose drug or alcohol use cause significant impairment or distress may have a substance use disorder (SUD).<ref name=\"DSM5\" /> Diagnosis usually involves an in-depth examination, typically by psychiatrist, psychologist, or drug and alcohol counselor.<ref name=\":4\">{{Cite web|url=https://www.mayoclinic.org/diseases-conditions/drug-addiction/symptoms-causes/syc-20365112|title=Drug addiction (substance use disorder) \u2013 Symptoms and causes|website=Mayo Clinic|access-date=7 December 2018}}</ref> The most commonly used guidelines are published in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).<ref name=\":4\" /> There are 11 diagnostic criteria which can be broadly categorized into issues arising from substance use related to loss of control, strain to one's interpersonal life, hazardous use, and pharmacologic effects.<ref name=\"DSM5\" />\n\nDSM-5 guidelines for the diagnosis of a substance use disorder requires that the individual have significant impairment or distress from their pattern of drug use, and at least two of the symptoms listed below in a given year.<ref name=\"DSM5\" />\n\n# Using more of a substance than planned, or using a substance for a longer interval than desired\n# Inability to cut down despite desire to do so\n# Spending substantial amount of the day obtaining, using, or recovering from substance use\n# Cravings or intense urges to use\n# Repeated usage causes or contributes to an inability to meet important social, or professional obligations\n# Persistent usage despite user's knowledge that it is causing frequent problems at work, school, or home\n# Giving up or cutting back on important social, professional, or leisure activities because of use\n# Using in physically hazardous situations, or usage causing physical or mental harm\n# Persistent use despite the user's awareness that the substance is causing or at least worsening a physical or mental problem\n# Tolerance: needing to use increasing amounts of a substance to obtain its desired effects\n# Withdrawal: characteristic group of physical effects or symptoms that emerge as amount of substance in the body decreases\n\nThere are additional qualifiers and exceptions outlined in the DSM. For instance, if an individual is taking [[opiate|opiates]] as prescribed, they may experience physiologic effects of tolerance and withdrawal, but this would not cause an individual to meet criteria for a SUD without additional symptoms also being present.<ref name=\"DSM5\" /> A medical professional trained to evaluate and treat substance use disorders will take these nuances into account during a diagnostic evaluation.\n\n=== Severity ===\nSubstance use disorders can range widely in severity, and there are numerous methods to monitor and qualify the severity of an individual's SUD. The DSM-5 includes specifiers for severity of a SUD.<ref name=\"DSM5\" /> Individuals who meet only 2 or 3 criteria are often deemed to have ''mild'' SUD.<ref name=\"DSM5\" /> Substance users who meet 4 or 5 criteria may have their SUD described as ''moderate,'' and persons meeting 6 or more criteria as ''severe.''<ref name=\"DSM5\" /> In the DSM-5, the term ''drug addiction'' is synonymous with ''severe substance use disorder''.<ref name=\"Brain disease\" /><ref name=\"Surgeon General severe SUD\">{{cite web | title=Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health | url=https://addiction.surgeongeneral.gov/sites/default/files/surgeon-generals-report.pdf | website = Office of the Surgeon General | publisher=US Department of Health and Human Services | date=November 2016 | access-date=28 January 2017 | pages = 35\u201337, 45, 63, 155, 317, 338 | quote = }}</ref> The quantity of criteria met offer a rough gauge on the severity of illness, but licensed professionals will also take into account a more holistic view when assessing severity which includes specific consequences and behavioral patterns related to an individual's substance use.<ref name=\"DSM5\" /> They will also typically follow frequency of use over time, and assess for substance-specific consequences, such as the occurrence of blackouts, or arrests for driving under the influence of alcohol, when evaluating someone for an alcohol use disorder.<ref name=\"DSM5\" /> There are additional qualifiers for stages of remission that are based on the amount of time an individual with a diagnosis of a SUD has not met any of the 11 criteria except craving.<ref name=\"DSM5\" /> Some medical systems refer to an Addiction Severity Index to assess the severity of problems related to substance use.<ref>Butler SF, Budman SH, Goldman RJ, Newman FL, Beckley KE, Trottier D. Initial Validation of a Computer-Administered Addiction Severity Index: The ASI-MV Psychology of Addictive Behaviors 2001 March</ref> The index assesses potential problems in seven categories: medical, employment/support, alcohol, other drug use, legal, family/social, and psychiatric.<ref>{{cite web|url=http://www.alcoholrehab.com|title=DARA Thailand|access-date=4 June 2017}}</ref>\n\n=== Screening tools ===\nThere are several different screening tools that have been validated for use with adolescents, such as the [[CRAFFT Screening Test|CRAFFT]], and with adults, such as [[CAGE questionnaire|CAGE]]. Laboratory tests to detect alcohol and other drugs in urine and blood may be useful during the assessment process to confirm a diagnosis, to establish a baseline, and later, to monitor progress.<ref name=\":10\">{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK64820/|title=Chapter 2\u2014Screening for Substance Use Disorders|last=Treatment|first=Center for Substance Abuse|date=1997|publisher=Substance Abuse and Mental Health Services Administration (US)}}</ref> However, since these tests measure recent substance use rather than chronic use or dependence, they are not recommended as screening tools.<ref name=\":10\" />\n\n==Mechanisms==\n{{Main|Addiction#Mechanisms|Substance dependence#Biomolecular mechanisms}}\n\n==Management==\n\n===Detoxification===\nDepending on the severity of use, and the given substance, early treatment of acute withdrawal may include medical [[Drug detoxification|detoxification]]. Of note, acute withdrawal from heavy alcohol use should be done under medical supervision to prevent a potentially deadly withdrawal syndrome known as [[delirium tremens]]. See also [[Alcohol detoxification]].\n\n===Therapy===\n{{main|Drug rehabilitation}}\nTherapists often classify people with chemical dependencies as either interested or not interested in changing. About 11% of Americans with substance use disorder seek treatment, and 40\u201360% of those people relapse within a year.<ref>{{cite journal | vauthors = McLellan AT, Lewis DC, O'Brien CP, Kleber HD | title = Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation | journal = JAMA | volume = 284 | issue = 13 | pages = 1689\u201395 | date = October 2000 | pmid = 11015800 | doi = 10.1001/jama.284.13.1689 | url = https://semanticscholar.org/paper/a575706c26cb86771c31fe35eef669aa29ad975f }}</ref> Treatments usually involve planning for specific ways to avoid the addictive stimulus, and therapeutic interventions intended to help a client learn healthier ways to find satisfaction. Clinical leaders in recent years have attempted to tailor intervention approaches to specific influences that affect addictive behavior, using therapeutic interviews in an effort to discover factors that led a person to embrace unhealthy, addictive sources of pleasure or relief from pain.\n{| class=\"wikitable\"  style=\"width:60%; margin:auto; background:FOF8FF;\"\n|- style=\"background:#afeeee; font-size:large;\"\n!colspan=3|Treatments\n|- style=\"background:#bfefff;\"\n!'''''Behavioral pattern'''''\n!'''''Intervention'''''\n!'''''Goals'''''\n|-\n|Low [[self-esteem]], anxiety, verbal hostility\n|Relationship therapy, client centered approach\n|Increase self-esteem, reduce hostility and anxiety\n|-\n|Defective personal constructs, ignorance of interpersonal means\n|[[Cognitive restructuring]] including directive and group therapies\n|Insight\n|-\n|Focal anxiety such as fear of crowds\n|Desensitization\n|Change response to same cue\n|-\n|Undesirable behaviors, lacking appropriate behaviors\n|Aversive conditioning, operant conditioning, counter conditioning\n|Eliminate or replace behavior\n|-\n|Lack of information\n|Provide information\n|Have client act on information\n|-\n|Difficult social circumstances\n|Organizational intervention, environmental manipulation, family counseling\n|Remove cause of social difficulty\n|-\n|Poor social performance, rigid interpersonal behavior\n|Sensitivity training, communication training, group therapy\n|Increase interpersonal repertoire, desensitization to group functioning\n|-\n|Grossly bizarre behavior\n|Medical referral\n|Protect from society, prepare for further treatment\n|- style=\"text-align:center;font-size:small\"\n|colspan=3|Adapted from: ''Essentials of Clinical Dependency Counseling'', Aspen Publishers\n|}\n\nFrom the [[applied behavior analysis]] literature and the [[behavioral psychology]] literature, several evidence-based intervention programs have emerged, such as behavioral marital therapy, community reinforcement approach, cue exposure therapy, and contingency management strategies.<ref>{{cite journal | vauthors = O'Donohue W, Ferguson KE | title = Evidence-Based Practice in Psychology and Behavior Analysis| journal = The Behavior Analyst Today| volume = 7| issue = 3| pages = 335\u2013350| year = 2006| url = http://www.baojournal.com| format =  |access-date=24 March 2008| doi = 10.1037/h0100155}}</ref><ref>{{cite journal | vauthors = Chambless DL | title = An update on empirically validated therapies| journal = Clinical Psychology| volume = 49| issue = | pages = 5\u201314| publisher = American Psychological Association| year = 1998| url = http://www.apa.org/divisions/div12/est/newrpt.pdf| doi =  | access-date = 24 March 2008|display-authors=etal}}</ref> In addition, the same author suggests that social skills training adjunctive to inpatient treatment of alcohol dependence is probably efficacious.\n\n=== Medication ===\n[[Medication-assisted treatment]] (MAT) refers to the combination of behavioral interventions and medications to treat substance use disorders.<ref>{{cite journal | vauthors = Bonhomme J, Shim RS, Gooden R, Tyus D, Rust G | title = Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options | journal = Journal of the National Medical Association | volume = 104 | issue = 7\u20138 | pages = 342\u201350 | date = July 2012 | pmid = 23092049 | pmc = 4039205 | doi = 10.1016/s0027-9684(15)30175-9 }}</ref> Certain medications can be useful in treating severe substance use disorders. In the United States five medications are approved to treat alcohol and opioid use disorders.<ref name=\":13\">{{Cite book|title=American Psychiatric Association practice guidelines for the treatment of psychiatric disorders.|last=American Psychiatric Association.|date=2002|publisher=The Association|isbn=0-89042-320-2|oclc=48656105}}</ref> There are no approved medications for cocaine, methamphetamine, or other substance use disorders as of 2002.<ref name=\":13\" />\n\nMedications, such as methadone and disulfiram, can be used as part of broader treatment plans to help a patient function comfortably without illicit opioids or alcohol.<ref>{{Cite book|title=Access to substance use disorder treatment in Massachusetts|last=Massachusetts. Center for Health Information and Analysis, issuing body.|oclc=911187572}}</ref> Medications can be used in treatment to lessen withdrawal symptoms. Evidence has demonstrated the efficacy of MAT at reducing illicit drug use and overdose deaths, improving retention in treatment, and reducing HIV transmission.<ref>{{Cite journal|title=Stigma Associated with Opioid Use Disorder and Medication Assisted Treatment|last=Holt|first=Dr. Harry|date=2019-07-15|doi = 10.31124/advance.8866331}}</ref><ref>{{cite journal | vauthors = Schwartz RP, Gryczynski J, O'Grady KE, Sharfstein JM, Warren G, Olsen Y, Mitchell SG, Jaffe JH | display-authors = 6 | title = Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009 | journal = American Journal of Public Health | volume = 103 | issue = 5 | pages = 917\u201322 | date = May 2013 | pmid = 23488511 | pmc = 3670653 | doi = 10.2105/ajph.2012.301049 }}</ref><ref>{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK424859/|title=EARLY INTERVENTION, TREATMENT, AND MANAGEMENT OF SUBSTANCE USE DISORDERS|last=Administration (US)|first=Substance Abuse and Mental Health Services|last2=General (US)|first2=Office of the Surgeon|date=November 2016|publisher=US Department of Health and Human Services}}</ref>\n\n== Epidemiology ==\n[[File:Drug use disorders world map - DALY - WHO2004.svg|thumb|upright=1.3|The [[disability-adjusted life year]], a measure of overall disease burden (number of years lost due to ill-health, disability or early death), from drug use disorders per 100,000&nbsp;inhabitants in 2004 \n{{columns-list|colwidth=10em|\n{{legend|#b3b3b3|no data}}\n{{legend|#ffff65|<40}}\n{{legend|#fff200|40-80}}\n{{legend|#ffdc00|80-120}}\n{{legend|#ffc600|120-160}}\n{{legend|#ffb000|160-200}}\n{{legend|#ff9a00|200-240}}\n{{legend|#ff8400|240-280}}\n{{legend|#ff6e00|280-320}}\n{{legend|#ff5800|320-360}}\n{{legend|#ff4200|360-400}}\n{{legend|#ff2c00|400\u2013440}}\n{{legend|#cb0000|>440}}\n}}]]\nRates of substance use disorders vary by nation and by substance, but the overall prevalence is high.<ref name=\":0\">{{Cite book|last=Galanter|first=Marc|last2=Kleber|first2=Herbert D.|last3=Brady|first3=Kathleen T. | name-list-format = vanc |date=17 December 2014|title=The American Psychiatric Publishing Textbook of Substance Abuse Treatment|url=|volume=|pages=|doi=10.1176/appi.books.9781615370030|isbn=978-1-58562-472-0}}</ref> On a global level, men are affected at a much higher rate than women.<ref name=\":0\" /> Younger individuals are also more likely to be affected than older adults.<ref name=\":0\" />\n\n=== United States ===\nIn 2017, roughly 7% of Americans aged 12 or older had a SUD in the past year.<ref name=\":1\">{{Cite web|url=https://www.samhsa.gov/data/nsduh/reports-detailed-tables-2017-NSDUH|title=Reports and Detailed Tables From the 2017 National Survey on Drug Use and Health (NSDUH) {{!}} CBHSQ|website=www.samhsa.gov|access-date=6 December 2018|date=11 September 2018}}</ref>  Rates of alcohol use disorder in the past year were just over 5%. Approximately 3% of people aged 12 or older had an illicit drug use disorder.<ref name=\":1\" /> The highest rates of illicit drug use disorder were among those aged 18 to 25 years old, at roughly 7%.<ref name=\":1\" /><ref name=\":0\" />\n\nThere were over 72,000 deaths from drug overdose in the United States in 2017,<ref name=\":2\">{{Cite web|url=https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates|title=Overdose Death Rates|last=Abuse|first=National Institute on Drug|date=9 August 2018|website=www.drugabuse.gov|access-date=6 December 2018}}</ref> which is a threefold increase from 2002.<ref name=\":2\" /> However the CDC calculates alcohol overdose deaths separately; thus, this 72,000 number does not include the 2,366 alcohol overdose deaths in 2017.<ref>Centers for Disease Control and Prevention, National Center for Health Statistics. [https://wonder.cdc.gov/controller/saved/D76/D78F796 Substance-induced cause, 2017, percent total, with standard error] from the Underlying Cause of Death 1999-2018 CDC WONDER Online Database. Accessed at http://wonder.cdc.gov/ucd-icd10.html on 18 March 2020 at 18:06 UTC.</ref> Overdose fatalities from synthetic opioids, which typically involve fentanyl, have risen sharply in the past several years to contribute to nearly 30,000 deaths per year.<ref name=\":2\" /> Death rates from synthetic opioids like fentanyl have increased 22-fold in the period from 2002 to 2017.<ref name=\":2\" /> Heroin and other natural and semi-synthetic opioids combined to contribute to roughly 31,000 overdose fatalities.<ref name=\":2\" /> Cocaine contributed to roughly 15,000 overdose deaths, while methamphetamine and benzodiazepines each contributed to roughly 11,000 deaths.<ref name=\":2\" /> Of note, the mortality from each individual drug listed above cannot be summed because many of these deaths involved combinations of drugs, such as overdosing on a combination of cocaine and an opioid.<ref name=\":2\" />\n\nDeaths from alcohol consumption account for the loss of over 88,000 lives per year.<ref>{{Cite web|vauthors=((Centers for Disease Control and Prevention)) | url=https://nccd.cdc.gov/DPH_ARDI/Default/Report.aspx?T=AAM&P=f6d7eda7-036e-4553-9968-9b17ffad620e&R=d7a9b303-48e9-4440-bf47-070a4827e1fd&M=8E1C5233-5640-4EE8-9247-1ECA7DA325B9&F=&D=|title=Alcohol and Public Health: Alcohol-Related Disease Impact (ARDI) |website=[[Centers for Disease Control and Prevention]] (CDC) | year=2013 |access-date=6 December 2018 }}</ref> Tobacco remains the leading cause of preventable death, responsible for greater than 480,000 deaths in the United States each year.<ref>{{Cite web|url=https://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/|title=Smoking and Tobacco Use; Fact Sheet; Fast Facts|date=9 May 2018|website=[[Centers for Disease Control and Prevention]] (CDC)|access-date=6 December 2018}}</ref> These harms are signifiant financially with total costs of more than $420 billion annually and more than $120 billion in healthcare.<ref>{{cite journal | vauthors = Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD | title = 2010 National and State Costs of Excessive Alcohol Consumption | journal = American Journal of Preventive Medicine | volume = 49 | issue = 5 | pages = e73\u2013e79 | date = November 2015 | pmid = 26477807 | doi = 10.1016/j.amepre.2015.05.031 }}</ref>\n\n=== Canada ===\nAccording to Statistics Canada (2018), approximately one in five Canadians aged 15 years and older experience a substance use disorder in their lifetime.<ref name=\":6\">{{Cite web|url=https://www.canada.ca/en/health-canada/services/substance-use/canadian-drugs-substances-strategy/strengthening-canada-approach-substance-use-issue.html|title=Strengthening Canada's Approach to Substance Use Issues|last=Canada|first=Health|date=2018-09-05|website=gcnws|access-date=2019-11-01}}</ref> In Ontario specifically, the disease burden of mental illness and addiction is 1.5 times higher than all cancers together and over 7 times that of all infectious diseases.<ref>{{Cite web|url=https://www.publichealthontario.ca/en/Health%20Topics/Health%20Promotion/Mental%20Health/Opening%20Eyes%20Opening%20Minds|title=Opening Eyes, Opening Minds: The Ontario Burden of Mental Illness and Addictions Report|website=Public Health Ontario|access-date=2019-11-01}}</ref> Across the country, the ethnic group that is statistically the most impacted by substance use disorders compared to the general population are the Indigenous peoples of Canada. In a 2019 Canadian study, it was found that Indigenous participants experienced greater substance-related problems than non-Indigenous participants.<ref>{{cite journal | vauthors = Bingham B, Moniruzzaman A, Patterson M, Distasio J, Sareen J, O'Neil J, Somers JM | title = Indigenous and non-Indigenous people experiencing homelessness and mental illness in two Canadian cities: A retrospective analysis and implications for culturally informed action | journal = BMJ Open | volume = 9 | issue = 4 | pages = e024748 | date = April 2019 | pmid = 30962229 | pmc = 6500294 | doi = 10.1136/bmjopen-2018-024748 }}</ref>\n\nStatistics Canada's Canadian Community Health Survey (2012) shows that alcohol was the most common substance for which Canadians met the criteria for abuse or dependence.<ref name=\":6\" /> Surveys on Indigenous people in British Columbia show that around 75% of residents on reserve feel alcohol use is a problem in their community and 25% report they have a problem with alcohol use themselves. However, only 66% of First Nations adults living on reserve drink alcohol compared to 76% of the general population.<ref>{{Cite web|url=https://www.heretohelp.bc.ca/aboriginal-mental-health-statistical-reality|title=Aboriginal Mental Health: The statistical reality {{!}} Here to Help|website=www.heretohelp.bc.ca|access-date=2019-11-01}}</ref> Further, in an Ontario study on mental health and substance use among Indigenous people, 19% reported the use of cocaine and opiates, higher than the 13% of Canadians in the general population that reported using opioids.<ref>{{Cite web|url=https://www.ccsa.ca/prescription-opioids-canadian-drug-summary|title=Prescription Opioids (Canadian Drug Summary) {{!}} Canadian Centre on Substance Use and Addiction|website=www.ccsa.ca|access-date=2019-11-01}}</ref><ref>{{cite journal | vauthors = Firestone M, Smylie J, Maracle S, McKnight C, Spiller M, O'Campo P | title = Mental health and substance use in an urban First Nations population in Hamilton, Ontario | journal = Canadian Journal of Public Health | volume = 106 | issue = 6 | pages = e375-81 | date = June 2015 | pmid = 26680428 | doi = 10.17269/CJPH.106.4923 | pmc = 6972211 | jstor = 90005913 }}</ref>\n\n=== Australia ===\nHistorical and ongoing colonial practices continue to impact the health of Indigenous Australians, with Indigenous populations being more susceptible to substance use and related harms.<ref name=\":11\">{{Cite journal|last=Berry|first=Stacey L|last2=Crowe|first2=Trevor P | name-list-format = vanc |date=January 2009|title=A review of engagement of Indigenous Australians within mental health and substance abuse services|journal=Australian e-Journal for the Advancement of Mental Health|volume=8|issue=1|pages=16\u201327|doi=10.5172/jamh.8.1.16|issn=1446-7984|url=https://ro.uow.edu.au/hbspapers/1043}}</ref> For example, alcohol and tobacco are the predominant substances used in Australia.<ref>{{cite journal | vauthors = Haber PS, Day CA | title = Overview of substance use and treatment from Australia | journal = Substance Abuse | volume = 35 | issue = 3 | pages = 304\u20138 | date = 2014 | pmid = 24853496 | doi = 10.1080/08897077.2014.924466 }}</ref> Although tobacco smoking is declining in Australia, it remains disproportionately high in Indigenous Australians with 45% aged 18 and over being smokers, compared to 16% among non-Indigenous Australians in 2014-2015.<ref name=\":12\">{{Cite web|url=https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia/contents/priority-populations/aboriginal-and-torres-strait-islander-people|title=Alcohol, tobacco & other drugs in Australia, Aboriginal and Torres Strait Islander people|website=Australian Institute of Health and Welfare|access-date=2019-11-24}}</ref> As for alcohol, while proportionately more Indigenous people refrain from drinking than non-Indigenous people, Indigenous people who do consume alcohol are more likely to do so at high-risk levels.<ref>{{Cite journal |last=Sanson-Fisher|first=Robert W|last2=Campbell|first2=Elizabeth M|last3=Perkins|first3=Janice J|last4=Blunden|first4=Steve V|last5=Davis|first5=Bob B | name-list-format = vanc |date=May 2006|title=Indigenous health research: a critical review of outputs over time|journal=Medical Journal of Australia|volume=184|issue=10|pages=502\u2013505|doi=10.5694/j.1326-5377.2006.tb00343.x|issn=0025-729X}}</ref> About 19% of Indigenous Australians qualified for risky alcohol consumption (defined as 11 or more standard drinks at least once a month), which is 2.8 times the rate that their non-Indigenous counterparts consumed the same level of alcohol.<ref name=\":12\" />\n\nHowever, while alcohol and tobacco usage are declining, use of other substances, such as cannabis and opiates, is increasing in Australia.<ref name=\":11\" /> Cannabis is the most widely used illicit drug in Australia, with cannabis usage being 1.9 times higher than non-Indigenous Australians.<ref name=\":12\" /> Prescription opioids have seen the greatest increase in usage in Australia, although use is still lower that in the US.<ref>{{cite journal | vauthors = Leong M, Murnion B, Haber PS | title = Examination of opioid prescribing in Australia from 1992 to 2007 | journal = Internal Medicine Journal | volume = 39 | issue = 10 | pages = 676\u201381 | date = October 2009 | pmid = 19460051 | doi = 10.1111/j.1445-5994.2009.01982.x }}</ref> In 2016, Indigenous persons were 2.3 times more likely to misuse pharmaceutical drugs than non-Indigenous people.<ref name=\":12\" />\n{{-}}\n\n== References ==\n{{reflist}}\n\n== Further reading ==\n* {{cite book | title = Concurrent substance use and mental health disorders : an information guide | isbn = 978-1-77052-604-4 | year = 2010 | vauthors = Skinner WW, O'Grady CP, Bartha C, Parker C | publisher = Centre for Addiction and Mental Health (CAMH) | url = http://www.camh.ca/-/media/files/guides-and-publications/concurrent-disorders-guide-en.pdf }}\n* {{cite book | title = Best Practices: Concurrent Mental Health and Substance Use Disorders | isbn = 0-662-31388-7 | url = http://www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/pubs/adp-apd/bp_disorder-mp_concomitants/bp_concurrent_mental_health-eng.pdf }}\n\n== External links ==\n{{Medical resources\n|  DiseasesDB     = \n|  ICD10          = {{ICD10|F|10||f|10}}-{{ICD10|F|19||f|10}} \n|  ICD9           = {{ICD9|303}}-{{ICD9|305}} \n|  ICDO           =  \n|  OMIM           =  \n|  MedlinePlus    =  \n|  eMedicineSubj  =  \n|  eMedicineTopic =  \n|  MeshID         = D019966\n}}\n\n{{Psychoactive substance use|state=expanded}}\n{{Reinforcement disorders|state=expanded}}\n\n{{Portal bar | Pharmacy and pharmacology | Medicine}}\n\n{{DEFAULTSORT:Substance Use Disorder}}\n[[Category:Addiction]]\n[[Category:Psychiatric diagnosis]]\n[[Category:Substance dependence]]\n[[Category:Substance-related disorders]]\n", "text_old": "{{short description|Continual use of drugs (including alcohol) despite detrimental consequences}}\n{{Use dmy dates|date=December 2018}}\n{{Infobox medical condition (new)\n| name            = Substance use disorder\n| synonyms        = Drug use disorder\n| image           = Syringe-1884784_1920.jpg\n| caption         = \n| pronounce       = \n| speciality      = [[Psychiatry]], [[clinical psychology]]\n| symptoms        = \n| complications   = \n| onset           = \n| duration        = \n| types           = \n| causes          = \n| risks           = \n| diagnosis       = \n| differential    = \n| prevention      = \n| treatment       = \n| medication      = \n| prognosis       = \n| frequency       = \n| deaths          = \n}}\n'''Substance use disorder''' ('''SUD'''), also known as a '''drug use disorder''', is the persistent use of drugs (including alcohol) despite substantial adverse consequences.<ref>{{Cite book|title=Diagnostic and statistical manual of mental disorders.|date=2013|publisher=American Psychiatric Association|isbn=978-0-89042-554-1|edition=5|page=483|location=Arlington, VA|oclc=830807378}}</ref><ref>{{cite web | url=http://www.nami.org/Content/ContentGroups/Policy/Issues_Spotlights/DSM5/Substance_Use_Disorder_Paper_4_13_2010.pdf | title=NAMI Comments on the APA's Dr aft Revision of the DSM-V Substance Use Disorders | publisher=National Alliance on Mental Illness | access-date=2 November 2013 | url-status=dead | archive-url=https://web.archive.org/web/20150122085833/http://www.nami.org/content/contentgroups/policy/issues_spotlights/dsm5/substance_use_disorder_paper_4_13_2010.pdf | archive-date=22 January 2015 }}</ref> Substance use disorders are characterized by an array of mental, physical, and behavioral symptoms that may cause problems related to loss of control, strain to one's interpersonal life, hazardous use, tolerance, and withdrawal.<ref name = \"DSM5\">{{cite book |title=Diagnostic and statistical manual of mental disorders. |publisher=American Psychiatric Association |isbn=978-0-89042-554-1 |edition=5 |date=2013 |url-access=registration |url=https://archive.org/details/diagnosticstatis0005unse }}</ref> Drug classes that are involved in SUD include: [[Alcoholism|alcohol]]; [[Caffeine dependence|caffeine]]; [[Cannabis (drug)|cannabis]]; hallucinogens (such as [[arylcyclohexylamine]]s); other hallucinogens (such as [[Lysergic acid diethylamide|LSD]]); [[inhalant]]s; [[Opioid use disorder|opioids]]; [[sedative]]s, [[hypnotic]]s, or [[anxiolytic]]s; [[stimulant]]s; [[Tobacco smoking|tobacco]]; and other or unknown substances.<ref>{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK519702/|title=Substance Use Disorders| author =Substance Abuse and Mental Health Services Administration |date=June 2016|publisher=Substance Abuse and Mental Health Services Administration (US)}}</ref>\n\nIn the [[DSM-5]], [[substance abuse]] and [[substance dependence]] have been merged into the category of substance use disorders.<ref>{{Cite journal|last=Guha|first=Martin | name-list-format = vanc |date=2014-03-11|title=Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (5th edition)|journal=Reference Reviews|volume=28 |issue=3 |doi=10.1108/RR-10-2013-0256|issn=0950-4125}}</ref><ref name=\"Hasin_2013\">{{cite journal | vauthors = Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF | display-authors = 6 | title = DSM-5 criteria for substance use disorders: recommendations and rationale | journal = The American Journal of Psychiatry | volume = 170 | issue = 8 | pages = 834\u201351 | date = August 2013 | pmid = 23903334 | pmc = 3767415 | doi = 10.1176/appi.ajp.2013.12060782 }}</ref> The severity of substance use disorders can vary widely; in the diagnosis of a SUD, the severity of an individual's SUD is qualified as ''mild'', ''moderate'', or ''severe'' on the basis of how many of the [[#Diagnosis|11 diagnostic criteria]] are met. In the DSM-5, the term ''drug addiction'' is synonymous with ''severe substance use disorder''.<ref name=\"Brain disease\" /><ref name=\"Surgeon General severe SUD\" />\n\n<!-- Epidemiology -->\nIn 2017 globally 271 million people (5.5% of adults) were estimated to have used one or more illicit drugs.<ref name=WDR2019>{{cite web |title=World Drug Report 2019: 35 million people worldwide suffer from drug use disorders while only 1 in 7 people receive treatment |url=https://www.unodc.org/unodc/en/frontpage/2019/June/world-drug-report-2019_-35-million-people-worldwide-suffer-from-drug-use-disorders-while-only-1-in-7-people-receive-treatment.html?ref=fs1#_ftnref1 |website=www.unodc.org |access-date=25 November 2019}}</ref> Of these 35 million had a substance use disorder.<ref name=WDR2019/>\n\nIn 2017 substance use disorders resulted in 585,000 deaths,<ref name=WDR2019/> up from 165,000 deaths in 1990.<ref name=\"GBD2015\" /><ref name=\"GDB2013\">{{cite journal | vauthors = Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, etal | collaboration = GBD 2013 Mortality and Causes of Death Collaborators | title = Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | journal = Lancet | volume = 385 | issue = 9963 | pages = 117\u201371 | date = January 2015 | pmid = 25530442 | pmc = 4340604 | doi = 10.1016/S0140-6736(14)61682-2 }}</ref> Of these, the highest numbers are from [[alcohol use disorders]] at 137,500, [[opioid use disorder]]s at 122,100 deaths, [[amphetamine use disorder]]s at 12,200 deaths, and [[cocaine use disorder]]s at 11,100.<ref name=\"GBD2015\">{{cite journal | title = Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 | journal = Lancet | volume = 388 | issue = 10053 | pages = 1459\u20131544 | date = October 2016 | pmid = 27733281 | pmc = 5388903 | doi = 10.1016/s0140-6736(16)31012-1 | last1 = Wang | first1 = Haidong | last2 = Naghavi | first2 = Mohsen | last3 = Allen | first3 = Christine | last4 = Barber | first4 = Ryan M. | last5 = Bhutta | first5 = Zulfiqar A. | last6 = Carter | first6 = Austin | last7 = Casey | first7 = Daniel C. | last8 = Charlson | first8 = Fiona J. | last9 = Chen | first9 = Alan Zian | last10 = Coates | first10 = Matthew M. | last11 = Coggeshall | first11 = Megan | last12 = Dandona | first12 = Lalit | last13 = Dicker | first13 = Daniel J. | last14 = Erskine | first14 = Holly E. | last15 = Ferrari | first15 = Alize J. | last16 = Fitzmaurice | first16 = Christina | last17 = Foreman | first17 = Kyle | last18 = Forouzanfar | first18 = Mohammad H. | last19 = Fraser | first19 = Maya S. | last20 = Fullman | first20 = Nancy | last21 = Gething | first21 = Peter W. | last22 = Goldberg | first22 = Ellen M. | last23 = Graetz | first23 = Nicholas | last24 = Haagsma | first24 = Juanita A. | last25 = Hay | first25 = Simon I. | last26 = Huynh | first26 = Chantal | last27 = Johnson | first27 = Catherine O. | last28 = Kassebaum | first28 = Nicholas J. | last29 = Kinfu | first29 = Yohannes | last30 = Kulikoff | first30 = Xie Rachel | displayauthors = 29 }}</ref> The number of deaths directly caused by drug use has increased over 60 percent from 2000 to 2015.<ref>{{Cite web|url=https://www.unodc.org/wdr2018/prelaunch/|title=Prelaunch|website=www.unodc.org|access-date=14 December 2018}}</ref>\n\n==Signs and symptoms==\nAddiction is a [[brain disorder]] characterized by compulsive drug use (i.e., the use of drugs due to irresistible urges or \"cravings\") despite negative consequences.<ref name=\":8\">{{Cite web|url=https://www.drugabuse.gov/publications/media-guide/science-drug-use-addiction-basics|title=The Science of Drug Use and Addiction: The Basics|last=Abuse|first=National Institute on Drug|website=www.drugabuse.gov|access-date=2019-11-19}}</ref> The medical community makes a distinction between [[physical dependence]] and [[psychological dependence]] upon drugs.<ref>{{Cite web|url=https://americanaddictioncenters.org/the-addiction-cycle/psychological-dependence|title=What Is Psychological Dependence?|last=Staff|first=Editorial|website=American Addiction Centers|access-date=2019-11-18}}</ref> [[Physical dependence]] refers to the process by which the body adapts to the drug, requiring more of it to achieve a certain effect (tolerance) and eliciting drug-specific symptoms upon cessation (characterized by symptoms of physical [[Drug withdrawal|withdrawal]] symptoms, like [[tremor]]s and sweating).<ref name=\":9\">{{Cite web|url=https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/frequently-asked-questions/there-difference-between-physical-dependence|title=Is there a difference between physical dependence and addiction?|last=Abuse|first=National Institute on Drug|website=www.drugabuse.gov|access-date=2019-11-19}}</ref> Conversely, [[psychological dependence]] occurs when a drug becomes central to a person's thoughts, emotions and activities.<ref name=\":7\">{{Cite web|url=https://www1.health.gov.au/internet/publications/publishing.nsf/Content/drugtreat-pubs-front6-fa-toc~drugtreat-pubs-front6-fa-secb~drugtreat-pubs-front6-fa-secb-8~drugtreat-pubs-front6-fa-secb-8-3|title=Department of Health {{!}} 8.3 Physical and psychological dependence|website=www1.health.gov.au|access-date=2019-11-19}}</ref> They may have strong desire to use the drug, despite being aware of its harmful effects.  A drug can cause physical dependence and not psychological dependence (for example, a person who is physically dependent on prescribed opioid medications may not experience a loss of control, strong cravings, etc.) and some can cause psychological dependence without physical dependence (the withdrawal symptoms associated with [[cocaine]] are all psychological, there is no associated vomiting or diarrhea as there is with opiate withdrawal).<ref>{{Cite web|url=https://www.centeronaddiction.org/the-buzz-blog/understanding-difference-between-physical-dependence-and-addiction|title=Understanding the Difference between Physical Dependence and Addiction {{!}} Center on Addiction|website=www.centeronaddiction.org|access-date=2019-11-19}}</ref>\n\n== Causes ==\nThere are many known risk factors associated with an increased chance of developing a substance use disorder. Children born to parents with SUDs have roughly a two-fold increased risk in developing a SUD compared to children born to parents without any SUDs.<ref name=\":5\">{{Cite book|title=Ferri's Clinical Advisor|last=Ferri|first=Fred|publisher=Elsevier|year=2019|isbn=|location=|pages=}}</ref> Taking highly addictive drugs, and those who develop SUDs in their teens are more likely to have continued symptoms into adulthood.<ref name=\":5\" />  Other common risk factors are being male, being under 25, having other mental health problems, and lack of familial support and supervision.<ref name=\":5\" /> [[Personality theories of addiction|Psychological risk factors]] include high [[impulsivity]], [[sensation seeking]], [[neuroticism]] and [[openness to experience]] in combination with low [[conscientiousness]].<ref>{{cite journal | vauthors = Belcher AM, Volkow ND, Moeller FG, Ferr\u00e9 S | title = Personality traits and vulnerability or resilience to substance use disorders | journal = Trends in Cognitive Sciences | volume = 18 | issue = 4 | pages = 211\u20137 | date = April 2014 | pmid = 24612993 | pmc = 3972619 | doi = 10.1016/j.tics.2014.01.010 }}</ref><ref>{{cite book |last1= Fehrman|first1= Elaine|last2=  Egan|first2=Vincent |last3= Gorban|first3= Alexander N. |last4= Levesley|first4= Jeremy |last5= Mirkes|first5= Evgeny M.  |last6= Muhammad|first6=Awaz K. | name-list-format = vanc |date= 2019|title= Personality Traits and Drug Consumption. A Story Told by Data|url= |doi= 10.1007/978-3-030-10442-9|location= |publisher= Springer, Cham|page= |isbn=978-3-030-10441-2 |author-link= |arxiv= 2001.06520  }}</ref>\n\n== Diagnosis ==\n{{addiction glossary|reverse citation order=yes}}\nIndividuals whose drug or alcohol use cause significant impairment or distress may have a substance use disorder (SUD).<ref name=\"DSM5\" /> Diagnosis usually involves an in-depth examination, typically by psychiatrist, psychologist, or drug and alcohol counselor.<ref name=\":4\">{{Cite web|url=https://www.mayoclinic.org/diseases-conditions/drug-addiction/symptoms-causes/syc-20365112|title=Drug addiction (substance use disorder) \u2013 Symptoms and causes|website=Mayo Clinic|access-date=7 December 2018}}</ref> The most commonly used guidelines are published in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).<ref name=\":4\" /> There are 11 diagnostic criteria which can be broadly categorized into issues arising from substance use related to loss of control, strain to one's interpersonal life, hazardous use, and pharmacologic effects.<ref name=\"DSM5\" />\n\nDSM-5 guidelines for the diagnosis of a substance use disorder requires that the individual have significant impairment or distress from their pattern of drug use, and at least two of the symptoms listed below in a given year.<ref name=\"DSM5\" />\n\n# Using more of a substance than planned, or using a substance for a longer interval than desired\n# Inability to cut down despite desire to do so\n# Spending substantial amount of the day obtaining, using, or recovering from substance use\n# Cravings or intense urges to use\n# Repeated usage causes or contributes to an inability to meet important social, or professional obligations\n# Persistent usage despite user's knowledge that it is causing frequent problems at work, school, or home\n# Giving up or cutting back on important social, professional, or leisure activities because of use\n# Using in physically hazardous situations, or usage causing physical or mental harm\n# Persistent use despite the user's awareness that the substance is causing or at least worsening a physical or mental problem\n# Tolerance: needing to use increasing amounts of a substance to obtain its desired effects\n# Withdrawal: characteristic group of physical effects or symptoms that emerge as amount of substance in the body decreases\n\nThere are additional qualifiers and exceptions outlined in the DSM. For instance, if an individual is taking opiates as prescribed, they may experience physiologic effects of tolerance and withdrawal, but this would not cause an individual to meet criteria for a SUD without additional symptoms also being present.<ref name=\"DSM5\" /> A medical professional trained to evaluate and treat substance use disorders will take these nuances into account during a diagnostic evaluation.\n\n=== Severity ===\nSubstance use disorders can range widely in severity, and there are numerous methods to monitor and qualify the severity of an individual's SUD. The DSM-5 includes specifiers for severity of a SUD.<ref name=\"DSM5\" /> Individuals who meet only 2 or 3 criteria are often deemed to have ''mild'' SUD.<ref name=\"DSM5\" /> Substance users who meet 4 or 5 criteria may have their SUD described as ''moderate,'' and persons meeting 6 or more criteria as ''severe.''<ref name=\"DSM5\" /> In the DSM-5, the term ''drug addiction'' is synonymous with ''severe substance use disorder''.<ref name=\"Brain disease\" /><ref name=\"Surgeon General severe SUD\">{{cite web | title=Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health | url=https://addiction.surgeongeneral.gov/sites/default/files/surgeon-generals-report.pdf | website = Office of the Surgeon General | publisher=US Department of Health and Human Services | date=November 2016 | access-date=28 January 2017 | pages = 35\u201337, 45, 63, 155, 317, 338 | quote = }}</ref> The quantity of criteria met offer a rough gauge on the severity of illness, but licensed professionals will also take into account a more holistic view when assessing severity which includes specific consequences and behavioral patterns related to an individual's substance use.<ref name=\"DSM5\" /> They will also typically follow frequency of use over time, and assess for substance-specific consequences, such as the occurrence of blackouts, or arrests for driving under the influence of alcohol, when evaluating someone for an alcohol use disorder.<ref name=\"DSM5\" /> There are additional qualifiers for stages of remission that are based on the amount of time an individual with a diagnosis of a SUD has not met any of the 11 criteria except craving.<ref name=\"DSM5\" /> Some medical systems refer to an Addiction Severity Index to assess the severity of problems related to substance use.<ref>Butler SF, Budman SH, Goldman RJ, Newman FL, Beckley KE, Trottier D. Initial Validation of a Computer-Administered Addiction Severity Index: The ASI-MV Psychology of Addictive Behaviors 2001 March</ref> The index assesses potential problems in seven categories: medical, employment/support, alcohol, other drug use, legal, family/social, and psychiatric.<ref>{{cite web|url=http://www.alcoholrehab.com|title=DARA Thailand|access-date=4 June 2017}}</ref>\n\n=== Screening tools ===\nThere are several different screening tools that have been validated for use with adolescents, such as the [[CRAFFT Screening Test|CRAFFT]], and with adults, such as [[CAGE questionnaire|CAGE]]. Laboratory tests to detect alcohol and other drugs in urine and blood may be useful during the assessment process to confirm a diagnosis, to establish a baseline, and later, to monitor progress.<ref name=\":10\">{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK64820/|title=Chapter 2\u2014Screening for Substance Use Disorders|last=Treatment|first=Center for Substance Abuse|date=1997|publisher=Substance Abuse and Mental Health Services Administration (US)}}</ref> However, since these tests measure recent substance use rather than chronic use or dependence, they are not recommended as screening tools.<ref name=\":10\" />\n\n==Mechanisms==\n{{Main|Addiction#Mechanisms|Substance dependence#Biomolecular mechanisms}}\n\n==Management==\n\n===Detoxification===\nDepending on the severity of use, and the given substance, early treatment of acute withdrawal may include medical [[Drug detoxification|detoxification]]. Of note, acute withdrawal from heavy alcohol use should be done under medical supervision to prevent a potentially deadly withdrawal syndrome known as [[delirium tremens]]. See also [[Alcohol detoxification]].\n\n===Therapy===\n{{main|Drug rehabilitation}}\nTherapists often classify people with chemical dependencies as either interested or not interested in changing. About 11% of Americans with substance use disorder seek treatment, and 40\u201360% of those people relapse within a year.<ref>{{cite journal | vauthors = McLellan AT, Lewis DC, O'Brien CP, Kleber HD | title = Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation | journal = JAMA | volume = 284 | issue = 13 | pages = 1689\u201395 | date = October 2000 | pmid = 11015800 | doi = 10.1001/jama.284.13.1689 | url = https://semanticscholar.org/paper/a575706c26cb86771c31fe35eef669aa29ad975f }}</ref> Treatments usually involve planning for specific ways to avoid the addictive stimulus, and therapeutic interventions intended to help a client learn healthier ways to find satisfaction. Clinical leaders in recent years have attempted to tailor intervention approaches to specific influences that affect addictive behavior, using therapeutic interviews in an effort to discover factors that led a person to embrace unhealthy, addictive sources of pleasure or relief from pain.\n{| class=\"wikitable\"  style=\"width:60%; margin:auto; background:FOF8FF;\"\n|- style=\"background:#afeeee; font-size:large;\"\n!colspan=3|Treatments\n|- style=\"background:#bfefff;\"\n!'''''Behavioral pattern'''''\n!'''''Intervention'''''\n!'''''Goals'''''\n|-\n|Low [[self-esteem]], anxiety, verbal hostility\n|Relationship therapy, client centered approach\n|Increase self-esteem, reduce hostility and anxiety\n|-\n|Defective personal constructs, ignorance of interpersonal means\n|[[Cognitive restructuring]] including directive and group therapies\n|Insight\n|-\n|Focal anxiety such as fear of crowds\n|Desensitization\n|Change response to same cue\n|-\n|Undesirable behaviors, lacking appropriate behaviors\n|Aversive conditioning, operant conditioning, counter conditioning\n|Eliminate or replace behavior\n|-\n|Lack of information\n|Provide information\n|Have client act on information\n|-\n|Difficult social circumstances\n|Organizational intervention, environmental manipulation, family counseling\n|Remove cause of social difficulty\n|-\n|Poor social performance, rigid interpersonal behavior\n|Sensitivity training, communication training, group therapy\n|Increase interpersonal repertoire, desensitization to group functioning\n|-\n|Grossly bizarre behavior\n|Medical referral\n|Protect from society, prepare for further treatment\n|- style=\"text-align:center;font-size:small\"\n|colspan=3|Adapted from: ''Essentials of Clinical Dependency Counseling'', Aspen Publishers\n|}\n\nFrom the [[applied behavior analysis]] literature and the [[behavioral psychology]] literature, several evidence-based intervention programs have emerged, such as behavioral marital therapy, community reinforcement approach, cue exposure therapy, and contingency management strategies.<ref>{{cite journal | vauthors = O'Donohue W, Ferguson KE | title = Evidence-Based Practice in Psychology and Behavior Analysis| journal = The Behavior Analyst Today| volume = 7| issue = 3| pages = 335\u2013350| year = 2006| url = http://www.baojournal.com| format =  |access-date=24 March 2008| doi = 10.1037/h0100155}}</ref><ref>{{cite journal | vauthors = Chambless DL | title = An update on empirically validated therapies| journal = Clinical Psychology| volume = 49| issue = | pages = 5\u201314| publisher = American Psychological Association| year = 1998| url = http://www.apa.org/divisions/div12/est/newrpt.pdf| doi =  | access-date = 24 March 2008|display-authors=etal}}</ref> In addition, the same author suggests that social skills training adjunctive to inpatient treatment of alcohol dependence is probably efficacious.\n\n=== Medication ===\n[[Medication-assisted treatment]] (MAT) refers to the combination of behavioral interventions and medications to treat substance use disorders.<ref>{{cite journal | vauthors = Bonhomme J, Shim RS, Gooden R, Tyus D, Rust G | title = Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options | journal = Journal of the National Medical Association | volume = 104 | issue = 7\u20138 | pages = 342\u201350 | date = July 2012 | pmid = 23092049 | pmc = 4039205 | doi = 10.1016/s0027-9684(15)30175-9 }}</ref> Certain medications can be useful in treating severe substance use disorders. In the United States five medications are approved to treat alcohol and opioid use disorders.<ref name=\":13\">{{Cite book|title=American Psychiatric Association practice guidelines for the treatment of psychiatric disorders.|last=American Psychiatric Association.|date=2002|publisher=The Association|isbn=0-89042-320-2|oclc=48656105}}</ref> There are no approved medications for cocaine, methamphetamine, or other substance use disorders as of 2002.<ref name=\":13\" />\n\nMedications, such as methadone and disulfiram, can be used as part of broader treatment plans to help a patient function comfortably without illicit opioids or alcohol.<ref>{{Cite book|title=Access to substance use disorder treatment in Massachusetts|last=Massachusetts. Center for Health Information and Analysis, issuing body.|oclc=911187572}}</ref> Medications can be used in treatment to lessen withdrawal symptoms. Evidence has demonstrated the efficacy of MAT at reducing illicit drug use and overdose deaths, improving retention in treatment, and reducing HIV transmission.<ref>{{Cite journal|title=Stigma Associated with Opioid Use Disorder and Medication Assisted Treatment|last=Holt|first=Dr. Harry|date=2019-07-15|doi = 10.31124/advance.8866331}}</ref><ref>{{cite journal | vauthors = Schwartz RP, Gryczynski J, O'Grady KE, Sharfstein JM, Warren G, Olsen Y, Mitchell SG, Jaffe JH | display-authors = 6 | title = Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009 | journal = American Journal of Public Health | volume = 103 | issue = 5 | pages = 917\u201322 | date = May 2013 | pmid = 23488511 | pmc = 3670653 | doi = 10.2105/ajph.2012.301049 }}</ref><ref>{{Cite book|url=https://www.ncbi.nlm.nih.gov/books/NBK424859/|title=EARLY INTERVENTION, TREATMENT, AND MANAGEMENT OF SUBSTANCE USE DISORDERS|last=Administration (US)|first=Substance Abuse and Mental Health Services|last2=General (US)|first2=Office of the Surgeon|date=November 2016|publisher=US Department of Health and Human Services}}</ref>\n\n== Epidemiology ==\n[[File:Drug use disorders world map - DALY - WHO2004.svg|thumb|upright=1.3|The [[disability-adjusted life year]], a measure of overall disease burden (number of years lost due to ill-health, disability or early death), from drug use disorders per 100,000&nbsp;inhabitants in 2004 \n{{columns-list|colwidth=10em|\n{{legend|#b3b3b3|no data}}\n{{legend|#ffff65|<40}}\n{{legend|#fff200|40-80}}\n{{legend|#ffdc00|80-120}}\n{{legend|#ffc600|120-160}}\n{{legend|#ffb000|160-200}}\n{{legend|#ff9a00|200-240}}\n{{legend|#ff8400|240-280}}\n{{legend|#ff6e00|280-320}}\n{{legend|#ff5800|320-360}}\n{{legend|#ff4200|360-400}}\n{{legend|#ff2c00|400\u2013440}}\n{{legend|#cb0000|>440}}\n}}]]\nRates of substance use disorders vary by nation and by substance, but the overall prevalence is high.<ref name=\":0\">{{Cite book|last=Galanter|first=Marc|last2=Kleber|first2=Herbert D.|last3=Brady|first3=Kathleen T. | name-list-format = vanc |date=17 December 2014|title=The American Psychiatric Publishing Textbook of Substance Abuse Treatment|url=|volume=|pages=|doi=10.1176/appi.books.9781615370030|isbn=978-1-58562-472-0}}</ref> On a global level, men are affected at a much higher rate than women.<ref name=\":0\" /> Younger individuals are also more likely to be affected than older adults.<ref name=\":0\" />\n\n=== United States ===\nIn 2017, roughly 7% of Americans aged 12 or older had a SUD in the past year.<ref name=\":1\">{{Cite web|url=https://www.samhsa.gov/data/nsduh/reports-detailed-tables-2017-NSDUH|title=Reports and Detailed Tables From the 2017 National Survey on Drug Use and Health (NSDUH) {{!}} CBHSQ|website=www.samhsa.gov|access-date=6 December 2018|date=11 September 2018}}</ref>  Rates of alcohol use disorder in the past year were just over 5%. Approximately 3% of people aged 12 or older had an illicit drug use disorder.<ref name=\":1\" /> The highest rates of illicit drug use disorder were among those aged 18 to 25 years old, at roughly 7%.<ref name=\":1\" /><ref name=\":0\" />\n\nThere were over 72,000 deaths from drug overdose in the United States in 2017,<ref name=\":2\">{{Cite web|url=https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates|title=Overdose Death Rates|last=Abuse|first=National Institute on Drug|date=9 August 2018|website=www.drugabuse.gov|access-date=6 December 2018}}</ref> which is a threefold increase from 2002.<ref name=\":2\" /> However the CDC calculates alcohol overdose deaths separately; thus, this 72,000 number does not include the 2,366 alcohol overdose deaths in 2017.<ref>Centers for Disease Control and Prevention, National Center for Health Statistics. [https://wonder.cdc.gov/controller/saved/D76/D78F796 Substance-induced cause, 2017, percent total, with standard error] from the Underlying Cause of Death 1999-2018 CDC WONDER Online Database. Accessed at http://wonder.cdc.gov/ucd-icd10.html on 18 March 2020 at 18:06 UTC.</ref> Overdose fatalities from synthetic opioids, which typically involve fentanyl, have risen sharply in the past several years to contribute to nearly 30,000 deaths per year.<ref name=\":2\" /> Death rates from synthetic opioids like fentanyl have increased 22-fold in the period from 2002 to 2017.<ref name=\":2\" /> Heroin and other natural and semi-synthetic opioids combined to contribute to roughly 31,000 overdose fatalities.<ref name=\":2\" /> Cocaine contributed to roughly 15,000 overdose deaths, while methamphetamine and benzodiazepines each contributed to roughly 11,000 deaths.<ref name=\":2\" /> Of note, the mortality from each individual drug listed above cannot be summed because many of these deaths involved combinations of drugs, such as overdosing on a combination of cocaine and an opioid.<ref name=\":2\" />\n\nDeaths from alcohol consumption account for the loss of over 88,000 lives per year.<ref>{{Cite web|vauthors=((Centers for Disease Control and Prevention)) | url=https://nccd.cdc.gov/DPH_ARDI/Default/Report.aspx?T=AAM&P=f6d7eda7-036e-4553-9968-9b17ffad620e&R=d7a9b303-48e9-4440-bf47-070a4827e1fd&M=8E1C5233-5640-4EE8-9247-1ECA7DA325B9&F=&D=|title=Alcohol and Public Health: Alcohol-Related Disease Impact (ARDI) |website=[[Centers for Disease Control and Prevention]] (CDC) | year=2013 |access-date=6 December 2018 }}</ref> Tobacco remains the leading cause of preventable death, responsible for greater than 480,000 deaths in the United States each year.<ref>{{Cite web|url=https://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/|title=Smoking and Tobacco Use; Fact Sheet; Fast Facts|date=9 May 2018|website=[[Centers for Disease Control and Prevention]] (CDC)|access-date=6 December 2018}}</ref> These harms are signifiant financially with total costs of more than $420 billion annually and more than $120 billion in healthcare.<ref>{{cite journal | vauthors = Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD | title = 2010 National and State Costs of Excessive Alcohol Consumption | journal = American Journal of Preventive Medicine | volume = 49 | issue = 5 | pages = e73\u2013e79 | date = November 2015 | pmid = 26477807 | doi = 10.1016/j.amepre.2015.05.031 }}</ref>\n\n=== Canada ===\nAccording to Statistics Canada (2018), approximately one in five Canadians aged 15 years and older experience a substance use disorder in their lifetime.<ref name=\":6\">{{Cite web|url=https://www.canada.ca/en/health-canada/services/substance-use/canadian-drugs-substances-strategy/strengthening-canada-approach-substance-use-issue.html|title=Strengthening Canada's Approach to Substance Use Issues|last=Canada|first=Health|date=2018-09-05|website=gcnws|access-date=2019-11-01}}</ref> In Ontario specifically, the disease burden of mental illness and addiction is 1.5 times higher than all cancers together and over 7 times that of all infectious diseases.<ref>{{Cite web|url=https://www.publichealthontario.ca/en/Health%20Topics/Health%20Promotion/Mental%20Health/Opening%20Eyes%20Opening%20Minds|title=Opening Eyes, Opening Minds: The Ontario Burden of Mental Illness and Addictions Report|website=Public Health Ontario|access-date=2019-11-01}}</ref> Across the country, the ethnic group that is statistically the most impacted by substance use disorders compared to the general population are the Indigenous peoples of Canada. In a 2019 Canadian study, it was found that Indigenous participants experienced greater substance-related problems than non-Indigenous participants.<ref>{{cite journal | vauthors = Bingham B, Moniruzzaman A, Patterson M, Distasio J, Sareen J, O'Neil J, Somers JM | title = Indigenous and non-Indigenous people experiencing homelessness and mental illness in two Canadian cities: A retrospective analysis and implications for culturally informed action | journal = BMJ Open | volume = 9 | issue = 4 | pages = e024748 | date = April 2019 | pmid = 30962229 | pmc = 6500294 | doi = 10.1136/bmjopen-2018-024748 }}</ref>\n\nStatistics Canada's Canadian Community Health Survey (2012) shows that alcohol was the most common substance for which Canadians met the criteria for abuse or dependence.<ref name=\":6\" /> Surveys on Indigenous people in British Columbia show that around 75% of residents on reserve feel alcohol use is a problem in their community and 25% report they have a problem with alcohol use themselves. However, only 66% of First Nations adults living on reserve drink alcohol compared to 76% of the general population.<ref>{{Cite web|url=https://www.heretohelp.bc.ca/aboriginal-mental-health-statistical-reality|title=Aboriginal Mental Health: The statistical reality {{!}} Here to Help|website=www.heretohelp.bc.ca|access-date=2019-11-01}}</ref> Further, in an Ontario study on mental health and substance use among Indigenous people, 19% reported the use of cocaine and opiates, higher than the 13% of Canadians in the general population that reported using opioids.<ref>{{Cite web|url=https://www.ccsa.ca/prescription-opioids-canadian-drug-summary|title=Prescription Opioids (Canadian Drug Summary) {{!}} Canadian Centre on Substance Use and Addiction|website=www.ccsa.ca|access-date=2019-11-01}}</ref><ref>{{cite journal | vauthors = Firestone M, Smylie J, Maracle S, McKnight C, Spiller M, O'Campo P | title = Mental health and substance use in an urban First Nations population in Hamilton, Ontario | journal = Canadian Journal of Public Health | volume = 106 | issue = 6 | pages = e375-81 | date = June 2015 | pmid = 26680428 | doi = 10.17269/CJPH.106.4923 | pmc = 6972211 | jstor = 90005913 }}</ref>\n\n=== Australia ===\nHistorical and ongoing colonial practices continue to impact the health of Indigenous Australians, with Indigenous populations being more susceptible to substance use and related harms.<ref name=\":11\">{{Cite journal|last=Berry|first=Stacey L|last2=Crowe|first2=Trevor P | name-list-format = vanc |date=January 2009|title=A review of engagement of Indigenous Australians within mental health and substance abuse services|journal=Australian e-Journal for the Advancement of Mental Health|volume=8|issue=1|pages=16\u201327|doi=10.5172/jamh.8.1.16|issn=1446-7984|url=https://ro.uow.edu.au/hbspapers/1043}}</ref> For example, alcohol and tobacco are the predominant substances used in Australia.<ref>{{cite journal | vauthors = Haber PS, Day CA | title = Overview of substance use and treatment from Australia | journal = Substance Abuse | volume = 35 | issue = 3 | pages = 304\u20138 | date = 2014 | pmid = 24853496 | doi = 10.1080/08897077.2014.924466 }}</ref> Although tobacco smoking is declining in Australia, it remains disproportionately high in Indigenous Australians with 45% aged 18 and over being smokers, compared to 16% among non-Indigenous Australians in 2014-2015.<ref name=\":12\">{{Cite web|url=https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia/contents/priority-populations/aboriginal-and-torres-strait-islander-people|title=Alcohol, tobacco & other drugs in Australia, Aboriginal and Torres Strait Islander people|website=Australian Institute of Health and Welfare|access-date=2019-11-24}}</ref> As for alcohol, while proportionately more Indigenous people refrain from drinking than non-Indigenous people, Indigenous people who do consume alcohol are more likely to do so at high-risk levels.<ref>{{Cite journal |last=Sanson-Fisher|first=Robert W|last2=Campbell|first2=Elizabeth M|last3=Perkins|first3=Janice J|last4=Blunden|first4=Steve V|last5=Davis|first5=Bob B | name-list-format = vanc |date=May 2006|title=Indigenous health research: a critical review of outputs over time|journal=Medical Journal of Australia|volume=184|issue=10|pages=502\u2013505|doi=10.5694/j.1326-5377.2006.tb00343.x|issn=0025-729X}}</ref> About 19% of Indigenous Australians qualified for risky alcohol consumption (defined as 11 or more standard drinks at least once a month), which is 2.8 times the rate that their non-Indigenous counterparts consumed the same level of alcohol.<ref name=\":12\" />\n\nHowever, while alcohol and tobacco usage are declining, use of other substances, such as cannabis and opiates, is increasing in Australia.<ref name=\":11\" /> Cannabis is the most widely used illicit drug in Australia, with cannabis usage being 1.9 times higher than non-Indigenous Australians.<ref name=\":12\" /> Prescription opioids have seen the greatest increase in usage in Australia, although use is still lower that in the US.<ref>{{cite journal | vauthors = Leong M, Murnion B, Haber PS | title = Examination of opioid prescribing in Australia from 1992 to 2007 | journal = Internal Medicine Journal | volume = 39 | issue = 10 | pages = 676\u201381 | date = October 2009 | pmid = 19460051 | doi = 10.1111/j.1445-5994.2009.01982.x }}</ref> In 2016, Indigenous persons were 2.3 times more likely to misuse pharmaceutical drugs than non-Indigenous people.<ref name=\":12\" />\n{{-}}\n\n== References ==\n{{reflist}}\n\n== Further reading ==\n* {{cite book | title = Concurrent substance use and mental health disorders : an information guide | isbn = 978-1-77052-604-4 | year = 2010 | vauthors = Skinner WW, O'Grady CP, Bartha C, Parker C | publisher = Centre for Addiction and Mental Health (CAMH) | url = http://www.camh.ca/-/media/files/guides-and-publications/concurrent-disorders-guide-en.pdf }}\n* {{cite book | title = Best Practices: Concurrent Mental Health and Substance Use Disorders | isbn = 0-662-31388-7 | url = http://www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/pubs/adp-apd/bp_disorder-mp_concomitants/bp_concurrent_mental_health-eng.pdf }}\n\n== External links ==\n{{Medical resources\n|  DiseasesDB     = \n|  ICD10          = {{ICD10|F|10||f|10}}-{{ICD10|F|19||f|10}} \n|  ICD9           = {{ICD9|303}}-{{ICD9|305}} \n|  ICDO           =  \n|  OMIM           =  \n|  MedlinePlus    =  \n|  eMedicineSubj  =  \n|  eMedicineTopic =  \n|  MeshID         = D019966\n}}\n\n{{Psychoactive substance use|state=expanded}}\n{{Reinforcement disorders|state=expanded}}\n\n{{Portal bar | Pharmacy and pharmacology | Medicine}}\n\n{{DEFAULTSORT:Substance Use Disorder}}\n[[Category:Addiction]]\n[[Category:Psychiatric diagnosis]]\n[[Category:Substance dependence]]\n[[Category:Substance-related disorders]]\n", "name_user": "TravelingRav16", "label": "safe", "comment": "added link back to wikipedia article to allow viewer to access more related information", "url_page": "//en.wikipedia.org/wiki/Substance_use_disorder"}
